丙泊酚镇静的儿科患者3T磁共振伪脑膜强化
研究纳入43例1-5岁接受丙泊酚镇静的儿童,评估3T增强脑MRI脑膜强化程度。自旋回波T1WI的强化等级(1.9-2.1)显著高于梯度回波T1WI(1.2-1.4,P<.0001),且与年龄和体重呈负相关,与丙泊酚剂量无关。作者认为该伪脑膜强化不应误诊为疾病。
要点
- 3T增强自旋回波T1WI上儿童脑膜强化等级显著高于梯度回波T1WI,属伪强化。
- 年龄越小、体重越低,丙泊酚镇静后伪脑膜强化越明显。
- 丙泊酚剂量、镇静时长及增强后扫描时间与强化等级无显著相关。
核心结论
- 丙泊酚镇静的幼儿在3T增强自旋回波T1WI上出现脑膜强化(伪脑膜强化)的频率和程度高于梯度回波T1WI,不应误认为病变;该现象在年龄更小或体型更小的患儿中可能更明显,可能源于丙泊酚诱导的血管平滑肌扩张。
研究设计与样本
- 2年期间152名1-5岁接受MRI的儿童中,43名纳入MRI回顾;37名接受增强后成像,其中仅梯度回波T1WI 20名、仅自旋回波T1WI 17名,6名两种序列均做;3名神经放射科医生独立分级脑膜强化程度(0-3级)并计算观察者间信度。
关键影像表现/征象
- 自旋回波T1WI上脑膜强化等级为1.9-2.1,梯度回波T1WI为1.2-1.4,自旋回波显著更高(P<.0001)。
- 患者体重与脑膜强化等级呈中度负相关(r=-0.366至-0.418,P=.003-.01)。
- 患者年龄与脑膜强化等级呈中度负相关(r=-0.315至-0.418,P=.004-.032)。
- 丙泊酚剂量、镇静持续时间及增强后至T1WI的时间与强化等级无显著相关(各项P>.05)。
诊断标准与关键数值
- 脑膜强化程度采用0-3级分级标准,由3名神经放射科医生独立评估。
- 自旋回波T1WI上观察者间信度κ=0.609-0.693(P<.0001),梯度回波T1WI上κ=0.567-0.698(P<.0001),均较强。
临床应用与阅片要点
- 在3T增强自旋回波T1WI上评估丙泊酚镇静幼儿时,脑膜强化可能为伪影,不应误判为疾病。
- 年龄更小或体重更低的患儿,伪脑膜强化可能更明显,阅片时需结合序列和患者因素综合判断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Propofol is a cerebral vasoconstrictor that modulates cerebral perfusion by decreasing the metabolic rate of oxygen. Because younger children often undergo intravenous sedation for MR imaging, this study set out to evaluate the degree of leptomeningeal contrast enhancement on 3T postcontrast brain MR imaging and to determine whether this phenomenon relates to sequence, sedation dosage, or patient age or weight.
MATERIALS AND METHODS: During a 2-year period, of 152 children 1-5 years of age who underwent MR imaging, 43 were included for MRI review. Of these, 37 underwent postcontrast imaging with either solely gradient-echo T1WI (n = 20) or spin-echo T1WI (n = 17); notably, 6 patients underwent both sequences. Three neuroradiologists separately graded the degree of leptomeningeal contrast enhancement (grades 0-3) that was correlated with various factors and calculated the interobserver reliability.
RESULTS: For the 43 patients, the mean patient age was 3.1 ± 1.4 years. The leptomeningeal contrast-enhancement grade was significantly greater (P < .0001) on spin-echo T1WI (1.9-2.1) versus gradient-echo TIWI (1.2-1.4). Patient weight (r = -0.366 to -.418, P = .003-.01) and age (r = -0.315 to -0.418, P = .004-.032) moderately and inversely correlated with the leptomeningeal contrast-enhancement grade, while the propofol dosage, sedation duration, and time to T1WI post-contrast administration did not (each, P > .05). The interobserver κ was strong regarding the leptomeningeal contrast-enhancement grade on both spin-echo T1WI (κ = 0.609-0.693, P < .0001) and gradient-echo TIWI (κ = 0.567-0.698, P < .0001).
CONCLUSIONS: Leptomeningeal contrast enhancement (or "pseudo"-leptomeningeal contrast enhancement) occurs with a greater frequency and degree on 3T postcontrast spin-echo T1WI relative to gradient-echo TIWI in younger children sedated with propofol and should not be mistaken for disease. This phenomenon may be more prominent with lower age or size and may arise from propofol-induced vascular smooth-muscle dilation.
引用
- McKinney AM, Chacko Achanaril A, Knoll B, et al. Pseudo-Leptomeningeal Contrast Enhancement at 3T in Pediatric Patients Sedated by Propofol. AJNR Am J Neuroradiol. 2018. PMID: 30049717. doi:10.3174/ajnr.A5736
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。